http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-221508-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9433d383d1922b3df0ca6c182c7d3925 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056 |
| filingDate | 1995-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f972b57342898c182c564cc8497e7450 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3445160d3f7d3e933bbcd0417bfcc4e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c776052c4ae3dbe77052d94660903ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9de723a2a2a3e70b7dfdbe11ae20e5cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f97310980bdf6ee1b806062a5c3426db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64ae32a4271e34a58d356924b5851dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_563ec6162b352ecbf786ef433548badb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_668a89942735ce9d99589e957b79cb98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0bd1ab5a628da73fec2b3110fc5047a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06096dd087f6d3377f3e3d512fdfc851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f221357b8559a5261267c6af19d9d953 |
| publicationDate | 2002-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-221508-B |
| titleOfInvention | 1-vinyl-5h-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them, process for the preparation of the compounds and intermediates |
| abstract | The present invention relates to novel benzodiazepine derivatives, pharmaceutical compositions containing them, and to their preparation. More particularly, the present invention provides 1- [2- (substituted) -vinyl] -5H-2,3-benzodiazepine derivatives and pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing them. The compounds of the invention may be represented by formula (I). In the formula A and B, taken together with the methyl group to which they are attached, represent a -C (CH3)? - or -CH (CH3) -NH- bond, the radical is fluorine, trifluoromethyl or cyano, and R1 and R2 together represent 7.8 or 8.9. -methylenedioxy group. The compounds of the invention exhibit outstanding anxiolytic activity, but are also free from the sedative effect of 1,4-benzodiazepine and 2,3-benzodiazepine derivatives of known anxiolytic activity. The invention also includes 2-benzopyryl perchlorate derivatives used in the production process. ŕ |
| priorityDate | 1995-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.